Argatroban-5 is primarily used as an anticoagulant in medical settings. It is often administered to prevent or treat blood clots in patients with heparin-induced thrombocytopenia (HIT), a condition where heparin use leads to a dangerous drop in platelet count. It works by directly inhibiting thrombin, a key enzyme in the blood clotting process. This makes it effective in managing thrombotic complications during surgeries or in patients with a high risk of clot formation. Additionally, it is sometimes used in patients undergoing percutaneous coronary interventions (PCI) to reduce the risk of clotting during the procedure. Its rapid onset and short half-life make it a suitable option for patients requiring precise anticoagulation control.